鱼疫苗市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00020208
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 180
Buy Now

【研究报告】2022年鱼疫苗市场规模为3.5588亿美元,预计到2030年将达到6.1738亿美元。预计2022-2030年复合年增长率为7.1%。
市场见解和分析师观点:
随着政府发展水产养殖业的举措不断加强以及对水生动物源性食品的需求激增,鱼疫苗市场规模正在不断扩大。此外,市场上新型鱼疫苗的开发预计将为鱼疫苗市场创造充足的机会。近年来,由于研究和技术的进步,鱼疫苗取得了长足的进步。传统疫苗存在局限性和缺点,这增加了对嵌合多表位疫苗等新型先进疫苗开发的需求。科学技术的进步为水产疫苗的基础和应用研究领域开辟了新的途径。
增长动力和挑战:
由于对海鲜的高需求和野生鱼类年捕捞量的减少,水产养殖呈指数级增长。因此,各国政府正在采取措施改善和支持水产养殖业的发展。例如,2021 年 2 月,食品与农业研究基金会 (FFAR) 资助 790,326 美元创建疫苗输送系统,帮助阻止罗非鱼湖病毒和其他疾病在水产养殖领域的传播。
不健康的饮食在发展中国家和发达国家日益受到关注,导致各种不良的健康后果。因此,为了健康生长和发育,强烈建议在饮食中加入鱼类,因为它富含维生素、矿物质、脂质和蛋白质等常量营养素。此外,水产养殖被认为是为人类可持续饮食生产高质量蛋白质的最有效方法。
开发有效的粘膜疫苗,同时加强管理流程,预计将加速新型疫苗的开发,这将促进全球水产养殖业的发展,规范鱼类疫苗接种流程。因此,新型鱼疫苗的开发可能会为市场增长创造重大机会。
鱼疫苗的使用必须得到使用国家或地区适当当局的批准。在任何使用或交易之前,必须遵守相关主管部门制定的具体规则和建议。授权和使用的立法、要求以及所涉及的监管机构可能因国家/地区而异。欧盟国家主管当局不能批准鱼类疫苗。欧洲药品管理局授权其在整个欧盟范围内使用。由于欧盟对疫苗制造商制定了严格的良好生产规范 (GMP) 准则,因此生产疫苗的成本很高。鱼类疫苗的市场比其他动物物种的疫苗要小,而且其开发成本也高于其他动物物种的疫苗。在美国,FDA 批准了鱼类疫苗。鱼类疫苗的开发需要10年或更长时间,耗资10-2000万美元。因此,严格的政府法规阻碍了市场的增长。
由寄生虫、病毒和细菌引起的疾病爆发的出现已经减缓了全球水产养殖业几十年的发展。除了危害人类健康外,新出现的疾病还对水生动物产生重大影响。传统疫苗存在局限性和缺点,这增加了对嵌合多表位疫苗等新型先进疫苗开发的需求。科学技术的进步为水产疫苗的基础和应用研究领域开辟了新的途径。人们正在努力利用新技术、方法和策略来创造更高质量和效率的新型水生疫苗。
利用现有的生物信息学工具以及免疫蛋白质组学和基因组学的现有知识,研究人员可以识别免疫细胞可以识别的潜在靶向表位认出。此外,随着全基因组测序等技术的成本持续下降,它为物种特异性疫苗的开发开辟了道路。这可能会增加开发新疫苗的投资。 2021年,中央咸水水产养殖研究所(ICAR)在印度推出了针对病毒性神经坏死(VNN)的重组疫苗。
因此,开发有效的粘膜疫苗并加强管理流程有望加速新型疫苗的研发的发展,这将促进地中海国家的水产养殖业,使鱼类疫苗接种过程规范化。因此,新型鱼类疫苗的开发可能会为市场增长创造重大机会
多样化新鱼类,特别是海水鱼类,是水产养殖领域的趋势。世界各地的农场越来越依赖疫苗接种来管理动物健康。具有广泛抗原多样性的新型病原体的发展也可能降低传统疫苗的有效性。这促使疫苗研究人员研究新技术,为水产养殖创造有效的疫苗。亚单位或重组 DNA/RNA 颗粒疫苗可能是使用现代疫苗技术制造的,该技术专注于特定的病原体成分。疫苗和疫苗学的最新进展使得寻找新的候选疫苗来对抗鱼类病原体(例如真菌和寄生虫)成为可能。借助遗传学、免疫学和生物技术新技术,鱼疫苗的开发和生产可以快速完成。这些技术包括使用基因工程载体、重组疫苗和 DNA 疫苗。
DNA 疫苗技术可有效预防鱼类疾病。将构建体和/或转基因靶向抗原受体细胞是提高DNA疫苗对抗其他病毒性疾病有效性的有希望的方法。分子组装体可用于靶向 DNA 疫苗中的树突状细胞 (DC) 和抗原呈递细胞 (APC),从而产生免疫反应。另一种策略是将 DNA 疫苗封装在特定载体中,以增加转基因和 MHC 表达。
基于重组 DNA 的疫苗或新一代疫苗的新型疫苗的开发广泛使用了 R DNA 技术。重组免疫原性蛋白疫苗或从携带原核或真核表达系统中产生的目的基因的载体纯化的表位、肽疫苗、通过确定的基因操作生产的活疫苗以及携带免疫原性蛋白和DNA疫苗编码基因的微生物载体都属于这些类型。已经开发出基于重组DNA技术的疫苗。重组疫苗的优点是密切模拟自然发生的感染,这有助于在经过治疗的鱼中触发有效的免疫反应。
战略见解
报告细分和范围:
鱼疫苗市场的划分依据疫苗类型、应用、给药途径和种类。根据疫苗类型,鱼疫苗市场分为灭活疫苗、活疫苗、亚单位疫苗、重组载体疫苗等。根据应用,鱼疫苗市场分为细菌疫苗、病毒疫苗和寄生虫疫苗。根据给药途径,鱼苗市场分为注射型、浸泡型和口服型。根据物种,鱼类疫苗市场分为鲑鱼、鳟鱼、罗非鱼等。根据地理位置,鱼疫苗市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太地区其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷) ,以及南美洲和中美洲其他地区)。
细分分析:
根据疫苗类型,鱼疫苗市场分为灭活疫苗、活疫苗、亚单位疫苗、重组载体疫苗等。灭活疫苗对水生动物施用后仍保持其免疫原性并导致这些动物产生特异性抵抗力。灭活疫苗采用物理或化学方法使高毒力病原微生物灭活。使用紫外线、高温加热、超声波和 G 射线是物理灭活技术的例子。化学灭活是通过使用化学物质分解有害细菌的核酸或蛋白质使有害细菌休眠的过程。与最广泛使用的灭活形式化学灭活相比,物理灭活困难、昂贵、受限且不稳定。灭活疫苗有助于对抗弧菌病、细杆菌病和弗朗西斯菌病等细菌性疾病的传播。灭活疫苗具有易于制备、储存和运输、安全性高、免疫原性稳定等优点。
预计不同国家/地区提供的灭活鱼疫苗将推动该领域的增长。例如,默克动物保健公司、默沙东动物保健公司、Pharmaq、Aquavac-vaccines和hipara提供的灭活疫苗已获得美国FDA批准用于治疗各种鱼类疾病,如弧菌病、疖病、鲶鱼肠败血症(ESC)和巴氏杆菌病。这些疫苗在不同地区/国家均有销售,例如美国、加拿大、日本、欧洲、澳大利亚、智利、越南、台湾、日本、巴西、印度尼西亚、挪威、英国、爱尔兰和冰岛。
鱼疫苗市场,按疫苗类型 - 2022 年和 2030 年
根据应用,鱼疫苗市场分为细菌、病毒和寄生虫。 2022 年,细菌细分市场占据最大市场份额,预计 2022-2030 年复合年增长率最高。水质差、水生环境的有机负荷、鱼类处理和运输不当以及温度的显着变化经常导致鱼类细菌性疾病,从而推动对有助于治疗鱼类细菌感染的疫苗的需求。
基于给药途径,鱼苗市场分为注射、浸泡、口服。 2022年,注入细分市场占据最大市场份额。预计2022年至2030年期间,浸泡部分的复合年增长率最高。
根据物种,鱼疫苗市场分为鲑鱼、鳟鱼、罗非鱼等。 2022年,鲑鱼细分市场占据最大市场份额。其他细分市场预计在 2022 年至 2030 年期间复合年增长率最高。
区域分析:
根据地理位置,鱼疫苗市场分为北美、欧洲、亚太地区、中东和非洲,以及南美洲和中美洲。北美是鱼疫苗市场增长的最大贡献者,亚太地区预计将成为未来几年增长最快的市场。北美市场的增长归因于美国水产养殖疫苗的增加。例如,根据世界银行的数据,美国生产了约 44.8 万吨水产养殖疫苗。据同一消息来源称,2021 年北美生产了约 560 万条鱼,其中约 470 万条产于美国,约占该地区总产量的 83%。正在进行的与鱼类免疫系统相关的研究,旨在开发更高效的疫苗,正在推动墨西哥市场的增长。例如,2022 年 12 月,新墨西哥大学生物系萨利纳斯实验室的研究人员在虹鳟鱼的鼻腔中发现了免疫结构,这将有助于了解虹鳟鱼疫苗的功效。
竞争格局和主要公司:Zoetis Inc.、Merck & Co Inc.、Hipra SA、Phibro Animal Health Corp、Vaxxinova International BV、Kyoto Biken Laboratories、Elanco Animal Health Inc.、Nisseiken Co., Ltd.、KBNP Inc.、 Choong Ang Vaccine Laboratories Co., Ltd. 和 INDIAN IMMUNOLOGICALS LTD.是鱼疫苗市场上的一些知名参与者。这些公司专注于扩大服务范围,以满足全球不断增长的消费者需求。他们的全球业务使他们能够为大量客户提供服务,从而扩大他们的市场份额。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a fish vaccine?

Vaccination is a quick, efficient, and preventative method of disease prevention for fish. Through the administration of vaccines, a protective immune response is induced in an animal during vaccination.

Who are the major players in the fish vaccine market?

The fish vaccine market majorly consists of the players such as Zoetis Inc., Merck & Co Inc., Hipra SA, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories, Elanco Animal Health Inc., Nisseiken Co., Ltd., KBNP Inc., Choong Ang Vaccine Laboratories Co., Ltd., and INDIAN IMMUNOLOGICALS LTD.

Which region is dominating the fish vaccine market?

North America region is dominating the fish vaccine market in terms of market share and Asia Pacific is anticipated to register the highest CAGR during 2022-2030.

Which segment is dominating the fish vaccine market?

The fish vaccine market is analyzed on the basis of vaccine type, application, route of administration, and species. Based on product, the market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on application, the market is classified as bacterial, viral, and parasitic. Based on route of administration, the market is segmented into injected, immersion, and oral. Based on species, the market is classified into salmon, trout, tilapia, and others

What are the driving factors for the global fish vaccine market worldwide?

The growth of the global fish vaccine market is attributed to a few key factors, such as the government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products.

The List of Companies - Fish Vaccine Market

  1. Zoetis Inc
  2. Merck & Co Inc
  3. Hipra SA
  4. Phibro Animal Health Corp
  5. Vaxxinova International BV
  6. Kyoto Biken Laboratories
  7. Elanco Animal Health Inc
  8. Nisseiken Co., Ltd.
  9. KBNP Inc
  10. Choong Ang Vaccine Laboratories Co., Ltd.
  11. INDIAN IMMUNOLOGICALS LTD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports